Change in Boardroom
| DUOPHARMA BIOTECH BERHAD |
| Date of change | 07 Jun 2024 |
| Name | DATIN PADUKA KARTINI BINTI HJ ABDUL MANAF |
| Age | 62 |
| Gender | Female |
| Nationality | Malaysia |
| Type of change | Redesignation |
| Previous Position | Independent Director |
| New Position | Chairman |
| Directorate | Non Independent and Non Executive |
Qualifications
| No | Qualifications |
Major/Field of Study |
Institute/University |
Additional Information |
|
Masters
|
Master of Business Administration |
Ohio University, USA |
|
|
|
Degree
|
Bachelor of Business Administration |
Ohio University, USA |
|
|
|
Diploma
|
Diploma in Banking Studies |
Universiti Teknologi MARA, Malaysia |
|
| Working experience and occupation | Datin Paduka Kartini Binti Hj Abdul Manaf was appointed as Independent Non-Executive Director of Duopharma Biotech Berhad on 1 June 2023. She was formerly the Deputy President of Strategic Investments at Permodalan Nasional Berhad (PNB), and had served PNB in various capacities for over 30 years until her retirement on 31 December 2019. At PNB, she served in various key positions, which were primarily related to investment management and corporate finance, including mergers and acquisitions, corporate restructuring, portfolio management, property investment and business development. |
| Family relationship with any director and/or major shareholder of the listed issuer | No |
| Any conflict of interests that he/she has with the listed issuer | No |
| Details of any interest in the securities of the listed issuer or its subsidiaries | No |
| Remarks : |
Following Datin Paduka Kartini's redesignation as a nominee Director of Permodalan Nasional Berhad (i.e. the Company's major shareholder) and redesignation as Non-Independent, Non-Executive Chairman of the Board, the incumbent has relinquished her position as the Independent, Non-Executive Director of Duopharma Biotech Berhad on even date. |
Announcement Info
| Company Name | DUOPHARMA BIOTECH BERHAD |
| Stock Name | DPHARMA |
| Date Announced | 06 Jun 2024 |
| Category | Change in Boardroom |
| Reference Number | C03-28052024-00003 |